You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 26, 2024

Lannett Co Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LANNETT CO INC, and what generic and branded alternatives to LANNETT CO INC drugs are available?

LANNETT CO INC has eighty-seven approved drugs.

There is one tentative approval on LANNETT CO INC drugs.

Summary for Lannett Co Inc

US Patents:	0
Tradenames:	68
Ingredients:	67
NDAs:	87
Drug Master File Entries:	1

Drugs and US Patents for Lannett Co Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lannett Co Inc	CETIRIZINE HYDROCHLORIDE	cetirizine hydrochloride	SOLUTION;ORAL	078496-001	Sep 25, 2009		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	FLUPHENAZINE HYDROCHLORIDE	fluphenazine hydrochloride	TABLET;ORAL	089743-001	Aug 25, 1988	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	091624-004	Apr 5, 2013	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	214403-004	Nov 26, 2021	AB1	RX	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	SYRUP;ORAL	078890-001	Jul 1, 2010		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	078281-001	Jan 20, 2011	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Lannett Co Inc	GLYCOLAX	polyethylene glycol 3350	FOR SOLUTION;ORAL	076652-001	Jul 2, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for LANNETT CO INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.